MENU
IMTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immatics (IMTX) Earnings Date & Reports

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients... Show more

A.I. Advisor
published Earnings

IMTX is expected to report earnings to fall 142.02% to -19 cents per share on May 20

Immatics IMTX Stock Earnings Reports
Q1'25
Est.
$-0.19
Q4'24
Beat
by $0.74
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.11
Q1'24
Beat
by $0.16
The last earnings report on March 27 showed earnings per share of 46 cents, beating the estimate of -28 cents. With 574.43K shares outstanding, the current market capitalization sits at 562.78M.
View a ticker or compare two or three
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Paul-Ehrlich-Strasse 15
Phone
+49 707153970
Employees
343
Web
https://www.immatics.com